XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Earnings
Noncontrolling Interest
Total
Beginning balance at Dec. 25, 2021 $ 61,902 $ 243,995 $ 1,678,121 $ (5,405) $ 37,956 $ 2,016,569
Increase (Decrease) in Stockholders' Equity            
Net earnings (loss)     189,703   3,428 193,131
Foreign currency translation adjustment       2,930 949 3,879
Unrealized gain (loss) on debt securities       (695)   (695)
Distributions to NCI         (2,053) (2,053)
Cash dividends     (12,541)     (12,541)
Issuance of shares under employee stock purchase plan 10 653       663
Net issuance (forfeitures) of shares under stock grant programs 787 8,959       9,746
Issuance of shares under deferred compensation plans 80 (80)        
Repurchase of shares (45)   (3,499)     (3,544)
Expense associated with share-based compensation arrangements   6,883       6,883
Accrued expense under deferred compensation plans   6,134       6,134
Ending balance at Mar. 26, 2022 62,734 266,544 1,851,784 (3,170) 40,280 2,218,172
Increase (Decrease) in Stockholders' Equity            
Net earnings (loss)     203,118   4,735 207,853
Foreign currency translation adjustment       (3,660) (95) (3,755)
Unrealized gain (loss) on debt securities       (628)   (628)
Cash dividends     (15,474)     (15,474)
Issuance of shares under employee stock purchase plan 14 781       795
Net issuance (forfeitures) of shares under stock grant programs 28 1,092       1,120
Issuance of shares under deferred compensation plans 12 (12)        
Repurchase of shares (1,165)   (88,506)     (89,671)
Expense associated with share-based compensation arrangements   5,556       5,556
Accrued expense under deferred compensation plans   1,100       1,100
Ending balance at Jun. 25, 2022 61,623 275,061 1,950,922 (7,458) 44,920 2,325,068
Beginning balance at Dec. 31, 2022 61,618 294,029 2,217,410 (9,075) 32,841 2,596,823
Increase (Decrease) in Stockholders' Equity            
Net earnings (loss)     126,069   (313) 125,756
Foreign currency translation adjustment       3,850 2,195 6,045
Unrealized gain (loss) on debt securities       151   151
Distributions to NCI         (4,859) (4,859)
Cash dividends     (15,642)     (15,642)
Issuance of shares under employee stock purchase plan 10 675       685
Net issuance (forfeitures) of shares under stock grant programs 825 14,356 6     15,187
Issuance of shares under deferred compensation plans 93 (93)        
Repurchase of shares (450)   (34,818)     (35,268)
Expense associated with share-based compensation arrangements   9,598       9,598
Accrued expense under deferred compensation plans   7,165       7,165
Ending balance at Apr. 01, 2023 62,096 325,730 2,293,025 (5,074) 29,864 2,705,641
Increase (Decrease) in Stockholders' Equity            
Net earnings (loss)     150,761   56 150,817
Foreign currency translation adjustment       2,983 1,694 4,677
Unrealized gain (loss) on debt securities       (199)   (199)
Other   427       427
Cash dividends     (15,507)     (15,507)
Issuance of shares under employee stock purchase plan 9 754       763
Net issuance (forfeitures) of shares under stock grant programs (1) 35       34
Issuance of shares under deferred compensation plans 12 (12)        
Repurchase of shares (251)   (19,965)     (20,216)
Expense associated with share-based compensation arrangements   8,201       8,201
Accrued expense under deferred compensation plans   1,213       1,213
Ending balance at Jul. 01, 2023 $ 61,865 $ 335,494 $ 2,408,314 $ (2,290) $ 31,614 $ 2,834,997